Insulet
PODD
#1133
Rank
NZ$26.81 B
Marketcap
$382.40
Share price
-0.46%
Change (1 day)
37.70%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Insulet (PODD) - Total debt

Total debt on the balance sheet as of June 2024 : NZ$2.25 B

According to Insulet's latest financial reports the company's total debt is NZ$2.25 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Insulet - Total debt on balance sheet (from 2005 to 2024)

Total debt by year

Year Total debt Change
2023-12-31NZ$2.23 B1.4%
2022-12-31NZ$2.20 B18.7%
2021-12-31NZ$1.86 B26.29%
2020-12-31NZ$1.47 B11.9%
2019-12-31NZ$1.31 B49.21%
2018-12-31NZ$0.88 B10.66%
2017-12-31NZ$0.79 B65.94%
2016-12-31NZ$0.48 B85.04%
2015-12-31NZ$0.25 B20.04%
2014-12-31NZ$0.21 B45.98%
2013-12-31NZ$0.14 B2.8%
2012-12-31NZ$0.14 B3.63%
2011-12-31NZ$0.13 B53.91%
2010-12-31NZ$90.36 M-32.82%
2009-12-31NZ$0.13 B28.96%
2008-12-31NZ$0.10 B202.11%
2007-12-31NZ$34.52 M-16.77%
2006-12-31NZ$41.47 M189.86%
2005-12-31NZ$14.31 M92727.7%
2004-12-31NZ$0.01 M-8.9%
2003-12-31NZ$0.01 M

Total debt for similar companies or competitors

Company Total debt differencediff. Country
NZ$2.71 B 20.07%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.77 B-65.84%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$4.19 B 85.60%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$67.06 B 2,868.31%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$23.84 B 955.52%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$45.04 B 1,893.49%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
NZ$46.70 B 1,966.96%๐Ÿ‡บ๐Ÿ‡ธ USA